EU may fast track approval of remdesivir as a COVID-19 treatment ahead of US

Reuters reports that the head of the European Medicines Agency said a conditional marketing authorisation could be issued in the coming days, amid high global demand for remdesivir. It has already recommended the compassionate use of remdesivir in EU.

Reuters Health